ARTICLE
|
doi:10.20944/preprints202402.0420.v1
Subject:
Medicine And Pharmacology,
Clinical Medicine
Keywords:
SARS-CoV-2; favipiravir; molnupiravir; diabetes mellitus; COVID-19
Online: 7 February 2024 (07:57:47 CET)